Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Covid-19 Anti-Vaccine Attitude and Hesitancy Publisher



Hasanzad M1, 2 ; Namazi H3 ; Larijani B2, 4
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2023


Abstract

High vaccination rates are required around the world to create herd immunity and terminate the current COVID-19 pandemic growth. With the steady rise in COVID-19 vaccine supplies, hesitancy and rejection to be vaccinated has become a problem worldwide for large vaccine coverage. Understanding the causes of vaccine avoidance or hesitancy can help to increase vaccination intentions in the general population. A number of factors contributed to increasing hesitancy. Some causes of COVID-19 vaccine hesitancy include anti-vaccine myths and confusing messages about some severe side effects of few vaccines, confusion over protection levels, poor health literacy (lack of accurate knowledge about vaccines and virus), deficient legal liability from the vaccine manufacturers, political and economic intentions, mistrust and suspicion of medical companies, concern of efficacy against to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants, safety concerns (elderly, people with preexisting comorbidities) and some socio-demographic factors. Urgent interventions and policies targeting the corresponding factors are needed. Recognizing obstacles to vaccine uptake helps in the development of effective solutions to solve them. Evidence-based and behaviorally guided approaches should be used to achieve high acceptance and uptake. © 2022, Springer Nature Switzerland AG.
Other Related Docs
6. Influenza Vaccination Attitudes of Health Care Workers in Iran, International Journal of Pharmacy and Technology (2016)
8. Covid-19: Significance of Antibodies, Human Antibodies (2020)
11. Covid-19 Vaccination Challenges: A Mini-Review, Human Vaccines and Immunotherapeutics (2022)
12. Update on Sars-Cov-2 Seroprevalence: Regional and Worldwide, Clinical Microbiology and Infection (2021)
19. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)